Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cerecor stock

Learn how to easily invest in Cerecor stock.

Cerecor is a biotechnology business based in the US. Cerecor shares (CERC) are listed on the NASDAQ and all prices are listed in US Dollars. Cerecor employs 30 staff and has a trailing 12-month revenue of around $6.4 million.

How to buy Cerecor stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – CERC. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Cerecor stock price (NASDAQ: CERC)

Use our graph to track the performance of CERC stocks over time.

Cerecor shares at a glance

Information last updated 2021-12-26.
52-week range$0.00 - $0.00
50-day moving average $2.88
200-day moving average $3.01
Wall St. target price$6.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.87

Buy Cerecor stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Cerecor stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cerecor price performance over time

Historical closes compared with the close of $N/A from 2021-11-26

1 week (2023-01-17) N/A
1 month (2022-12-24) N/A
3 months (2022-10-24) N/A
6 months (2022-07-24) N/A
1 year (2022-01-24) N/A
2 years (2021-01-28) -100.00%
3 years (2020-01-28) -100.00%
5 years (2018-01-26) -100.00%

Cerecor financials

Revenue TTM $6.4 million
Gross profit TTM $-18,536,584
Return on assets TTM -72.52%
Return on equity TTM -213.81%
Profit margin 0%
Book value $0.23
Market capitalisation $285 million

TTM: trailing 12 months

Cerecor share dividends

We're not expecting Cerecor to pay a dividend over the next 12 months.

Cerecor share price volatility

Over the last 12 months, Cerecor's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

CERC.US volatility(beta: 1.44)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cerecor's is 1.4406. This would suggest that Cerecor's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cerecor overview

Cerecor Inc. , a biopharmaceutical company, focuses on development and commercialization of treatments for rare and orphan diseases. The company develops monosaccharide therapies for the treatment of congenital disorders of glycosylation, such as CERC-801, CERC-802, and CERC-803. It is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of adult onset stills disease and multiple myeloma, as well as for the treatment of systemic juvenile idiopathic arthritis; CERC-006, an oral mTORC1/2 inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody that is in phase 2 clinical trial for the treatment of COVID-19 acute respiratory distress syndrome, as well as for the treatment of pediatric-onset Crohn's diseases. In addition, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. Cerecor Inc. has a collaboration agreement with The Frontiers in Congenital Disorders of Glycosylation Consortium on pivotal trial of CERC-801 for the treatment of Phosphoglucomutase-1 deficiency related congenital disorders of glycosylation.

Frequently asked questions

What percentage of Cerecor is owned by insiders or institutions?
Currently 0.79% of Cerecor shares are held by insiders and 70.39% by institutions.
How many people work for Cerecor?
Latest data suggests 30 work at Cerecor.
When does the fiscal year end for Cerecor?
Cerecor's fiscal year ends in December.
Where is Cerecor based?
Cerecor's address is: 540 Gaither Road, Rockville, MD, United States, 20850
What is Cerecor's ISIN number?
Cerecor's international securities identification number is: US05338F1084
What is Cerecor's CUSIP number?
Cerecor's Committee on Uniform Securities Identification Procedures number is: 15671L208

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site